Feedback
Settings

Settings

Goto Application

1. WO2005123731 - PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS

PermaLink
Publication Number WO/2005/123731
Publication Date 29.12.2005
International Application No. PCT/EP2005/006493
International Filing Date 16.06.2005
IPC
C07D 471/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61K 31/437 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
CPC
A61K 31/437
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 11/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
A61P 11/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
08Bronchodilators
A61P 11/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
14Antitussive agents
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
Applicants
  • NOVARTIS AG [CH]/[CH] (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SI, SK, SL, SM, SN, SY, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW)
  • NOVARTIS PHARMA GMBH [AT]/[AT] (AT)
  • BALA, Kamlesh [GB]/[GB] (UsOnly)
  • LEBLANC, Catherine [FR]/[GB] (UsOnly)
  • SANDHAM, David, Andrew [GB]/[GB] (UsOnly)
  • TURNER, Katharine, Louise [GB]/[GB] (UsOnly)
  • WATSON, Simon, James [GB]/[GB] (UsOnly)
  • BROWN, Lyndon, Nigel [GB]/[GB] (UsOnly)
  • COX, Brian [GB]/[GB] (UsOnly)
Inventors
  • BALA, Kamlesh
  • LEBLANC, Catherine
  • SANDHAM, David, Andrew
  • TURNER, Katharine, Louise
  • WATSON, Simon, James
  • BROWN, Lyndon, Nigel
  • COX, Brian
Agents
  • DE WEERD, Peter
Priority Data
0413619.817.06.2004GB
0507693.015.04.2005GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS
(FR) COMPOSES ORGANIQUES
front page image
Abstract
(EN)
There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
(FR)
L'invention concerne des composés, libres ou sous forme de sels, représentés par la formule (I), dans laquelle R1, R2, R3, R4, R5, R6, Q, W, X, m, n et p sont comme spécifiés dans le descriptif, le procédé de fabrication de ces composés et leur utilisation comme produits pharmaceutiques.
Also published as
MYPI 20052685
AR049443
PE2006-0301
ES2294717
DE602005003365
PT1761529
EP1761529
RU02379309
US20080114022
CN101035786
CA2569125
AU2005254681
DK1761529
ID047.0375
BRPI0512060
JP2008502638
PH1/2006/502389
RS50552
ZA2006/09527
NZ551439
IL179604
IN7126/DELNP/2006
TN2006000410
MXPA/a/2006/014694
MA28666
KR1020070032694
US20100204225
US20100210610
US20130267518
US20140309254
Latest bibliographic data on file with the International Bureau
# -